Add Yahoo as a preferred source to see more of our stories on Google. Instead of teaching the immune system to create antibodies to fight off a specific virus, the new vaccine would instead teach the ...

Add Yahoo as a preferred source to see more of our stories on Google. HERVs, or human endogenous retroviruses, make up around 8% of the human genome, left behind as a result of infections that ...

The acquisition is Lilly’s latest push into genetic medicine, giving it a technology designed to overcome some of the field’s longstanding limitations.

During the early stages of a pandemic, viruses tend to evolve in ways that enhance their ability to reproduce and spread, rather than to evade the host's immune system. The genetics and sex of the ...

A new study, led by Jesmond Dalli, professor of molecular pharmacology at Queen Mary University of London, has found that people with a genetic mutation that leads to a reduction in a protein called ...

People understand that someone can be predisposed to mental illness by inheriting certain genes or gene variants, but new research is revealing that inherited mental illnesses are also promoted by ...

Around one million individuals worldwide become infected with HIV, the virus that causes AIDS, each year. To replicate and spread the infection, the virus must smuggle its genetic material into the ...

With the current pandemic of bird flu – avian influenza – there is a growing concern around diseases spilling over from animals to humans. The COVID-19 pandemic highlighted the devastating impact such ...

Gene therapy is defined as the treatment of disease by transfer of genetic material into cells, to prevent, treat and potentially even cure a disease. Gene therapies can work by several mechanisms: 1) ...

The abundance of viral DNA was measured in DNA sequenced from blood and saliva samples in biobanks, revealing strong correlations with age, sex and dozens of genetic variants. Genetic analyses ...

Eli Lilly (NYSE:LLY) has agreed to acquire Engage Biologics in a deal worth up to $202 million. Engage Biologics is developing Tethosome, a non-viral DNA delivery platform for genetic medicines. This ...